Does Treatment Change with Gender in Acute Coronary Syndrome?

Abstract

333Abstract Coronary artery disease (CAD) is the leading cause of death in women, with higher mortality and morbidity compared to men. We sought to evaluate whether an inequality in the primary medical treatment of acute myocardial infarction (AMI) exists in a sample population in a tertiary care hospital setting. There were no statistically significant differences in use of beta receptor blockers, aspirin, cholesterol lowering agent or cclopidogrel in both genders. However, women were slightly more likely to receive angiotensin converting enzyme inhibitor. There is an extensive literature suggesting gender bias in the management of patients with AMI, with women being treated less intensively than men. Our research highlights the fact that there were no statistically significant differences in the AMI medical management. Clinical management of men and women with AMI is similar and should follow the standard of care recommended by the related guidelines.